Scrutiny of gene therapy broadens, intensifies

Article Abstract:

The safety of participants in gene therapy clinical trials has been enhansed by measures adopted by officials of the US Food and Drug Administration (FDA) and the National Institutes of Health. All sponsors of gene therapy will be required to submit substantial additional information to the FDA.

Government regulation (cont)

---

When the Human Genome Jproject and State Street collide

Article Abstract:

Patent litigation involving biotechnology, which has always been complicated is about to become even more difficult. With the escalation of bioinformatics has come a new class of patents.

Patents & copyrights

---

Piecing together more efficient gene expression

Article Abstract:

Researchers described a new method that would create a more effective muscle-specific transcriptor promoter gene to be used in therapeutic and transgenic applications.

Science & research, Brief Article

Similar abstracts:

• Abstracts: Preparation prevents blunders abroad: exhibiting internationally? Here are 5 basic guidelines for success. Exhibition association names Ducate to succeed Sind
• Abstracts: Transforming portfolio management. Re-thinking the credit process. The uneasy relationship
• Abstracts: An induction gene trap for identifying a homeoprotein-regulated locus. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
• Abstracts: Promotion helps reader catch the bug, increases brand awareness. Successful mortgage contest drives circulation, helps brand
• Abstracts: Bargain hunters drop into Asia. Mountain climbing telcos. Stay on the ball

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.